On Thursday afternoon, and FDA advisory panel recommended approval of Spark Therapeutics Inc ONCE 0.68%’s Luxturna treatment for inherited blindness. A number of Wall Street analysts weighed in on the stock following the news.
With the stock under pressure in early Friday trading, Square Inc SQ 3.29% investors are at risk of seeing something in their portfolio they haven’t seen in nearly three weeks: the color red. Since the stock last closed in the red on Sept. 22, Square has delivered an incredible 14 consecutive days of gains which have sent the…
H.C. Wainwright has initiated bullish coverage of four healthcare stocks headed into the end of 2017. Analyst Edward White explained his positive take on the four stocks in a research note on Thursday. Here’s a rundown of what he had to say.
It’s hard to imagine that Ulta Beauty Inc ULTA 0.79% stock was trading above $314 per share less than five months ago. Ulta shares dipped as low as $189.50 on Thursday morning after analysts at Cleveland Research downgraded the stock from Buy to Neutral and said Ulta stock still isn’t cheap considering the challenging environment it is facing…
Casino stocks are selling off in mid-morning trading on news out of Macau that Chinese travelers decided not to try their luck over the Golden Week holiday.
Shopify Inc (US) SHOP 3.07% stock has been all over the map so far in 2017, surging from under $45 per share at the beginning of the year to as high as $123.94 in September. However, the stock has since tanked to below $90 per share before rebounding to trade at around $95.70 on Wednesday.
Kroger Co KR 0.59% stock jumped more than 5 percent on Wednesday after the company revealed it’s considering selling 784 of its convenience stores, which include brands such as Turkey Hill Minit Markits, Loaf ‘N Jug, KwikShop, Tom Thumb and QuickStop. The company has hired Goldman Sachs to help it review its options.
Amazon.com, Inc. AMZN 0.33% has been the talk of Wall Street for years now due to its disruptive retail track record and disruptive potential in new markets, such as the pharmacy business. But despite the trail of dead Amazon has left in the retail sector, one unlikely company has overcome the odds and thrived in presence of the…
It’s been a long road for MannKind Corporation MNKD 0.61% and its Afrezza inhalable insulin product. However, a generous new FDA label this week may be the light at the end of the tunnel. Here’s a look at inhalable insulin’s long journey and what the new FDA ruling means for MannKind.
Corcept Therapeurtics Incorporated CORT 0.23% shares are down more than 7 percent Tuesday after the company seemingly reported a steep decline in Korlym prescriptions. However, the stock is bouncing off its lows on what Stifel analyst Adam Walsh says is a simple misunderstanding.